FIREStonesNCT05916963
Impact of Forced Diuresis on the Residual Fragment Rate After Flexible Ureteroscopy for Destruction of Kidney Stones With Laser
At risk: Primary completion moved at least 1 year 11 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 5 versions: 5 with changes below. See every version on ClinicalTrials.gov ↗
Notable Primary and study completion pushed from Apr 3, 2026 to Apr 2028 Show 4 more changesShow less
- Eligibility criteria expanded, about 17 words
- Secondary endpoints: details revised at 2 of 4 entries
- Site details revised at 1 of 9 sites
- Publications: details revised at 1 of 1 entry
- Notable Trial status: Not Yet Recruiting to Recruiting
- Study sites: 0 to 9
- Primary and study completion dates: Mar 15, 2026 to Apr 3, 2026
- Start date changed from estimate of Dec 15, 2023 to Jan 4, 2024
- Notable Start date: Oct 15, 2023 to Dec 15, 2023
- Primary and study completion dates: Jan 15, 2026 to Mar 15, 2026
Notable Eligibility criteria expanded, about 38 wordsv2 Show 4 more changesShow less
- Primary endpoint revised
- Secondary endpoints: 3 to 4
- Study description expanded, about 270 words
- Study title shortened, about 10 words
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Rate of stone free patients
Timeframe: At 3 months
Secondary (4)
Rate of urinary infection
Pain in a scale
Opioid consumption
Number of participants with adverse events
Arms and interventions
FurosemideExperimental
Injection of 40 mg of Furosemide during 10 minutes after the end of the flexible ureteroscopy for destruction of kidney stones with laser.
Usual careNo intervention
Usual care, without injection of Furosemide.
Drugs: Furosemide 40 mg
Sites
9 sites in 1 country